FdaApplication
ANDA 215917
Identifiers
- fda_app_no: ANDA215917
Properties
| Property | Value |
|---|---|
| applicant_name | DR REDDYS LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2024-05-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EDARAVONE | EDARAVONE | 60MG/100ML (0.6MG/ML) | SOLUTION;INTRAVENOUS |
1 product